0001209191-18-045430.txt : 20180803 0001209191-18-045430.hdr.sgml : 20180803 20180803191636 ACCESSION NUMBER: 0001209191-18-045430 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180801 FILED AS OF DATE: 20180803 DATE AS OF CHANGE: 20180803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Campbell Laura K CENTRAL INDEX KEY: 0001402605 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33876 FILM NUMBER: 18993207 MAIL ADDRESS: STREET 1: 3201 CARNEGIE AVENUE CITY: CLEVELAND STATE: OH ZIP: 44115 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ATHERSYS, INC / NEW CENTRAL INDEX KEY: 0001368148 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 204864095 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3201 CARNEGIE AVENUE CITY: CLEVELAND STATE: OH ZIP: 44115-2634 BUSINESS PHONE: 216-431-9900 MAIL ADDRESS: STREET 1: 3201 CARNEGIE AVENUE CITY: CLEVELAND STATE: OH ZIP: 44115-2634 FORMER COMPANY: FORMER CONFORMED NAME: BTHC VI Inc DATE OF NAME CHANGE: 20060629 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-08-01 0 0001368148 ATHERSYS, INC / NEW ATHX 0001402605 Campbell Laura K 3201 CARNEGIE AVENUE CLEVELAND OH 44115-2634 0 1 0 0 Senior Vice Pres Finance Common Stock 2018-08-01 4 S 0 4700 2.0048 D 602944 D Common Stock 2018-08-02 4 S 0 9720 2.0052 D 593224 D Shares sold pursuant to a Rule 10b5-1 trading plan that commenced in July 2018. A predefined number of shares may be sold from time-to-time based on predefined price increases over a two-year period. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.00 to $2.02, inclusive. Securities beneficially owned are comprised of: (1) 436,272 shares of common stock owned and (2) unvested restricted stock units aggregating 156,952 related to annual awards, which vest quarterly over a three or four-year period from grant date. /s/ Laura K. Campbell 2018-08-03